Two New Appointees at the NCI

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 9
Volume 4
Issue 9

BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology, Thomas Jefferson University, Philadelphia, has been appointed chief of NCI's Radiation Research Program. She is former president of the American Radium Society and the American Cancer Society, Philadelphia Division.

BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology,Thomas Jefferson University, Philadelphia, has been appointedchief of NCI's Radiation Research Program. She is former presidentof the American Radium Society and the American Cancer Society,Philadelphia Division.

Kenneth Cowan, MD, head of the NCI Medicinal Breast Cancer Section,will serve as acting chief of the Medicine Branch, temporarilyreplacing Robert Wittes, MD, acting director of the Division ofCancer Treatment.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Related Content